<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; bioengineering</title>
	<atom:link href="http://pharmaexecnews.com/tag/bioengineering/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>ACT Inc Receives Patent for Generating Embryonic Stem Cells minus Embryo Destruction</title>
		<link>http://pharmaexecnews.com/biotechnology/act-receives-patent-generating-embryonic-stem-cells-embryo-destruction/</link>
		<comments>http://pharmaexecnews.com/biotechnology/act-receives-patent-generating-embryonic-stem-cells-embryo-destruction/#comments</comments>
		<pubDate>Thu, 17 Mar 2011 08:00:40 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[understanding stem cell research]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11316</guid>
		<description><![CDATA[In a revolutionary development, Advanced Cell Technology, Inc., a leading biotechnology company applying cellular technology in the field of regenerative medicine, has announced that it has gotten the go ahead for developing its single-blastomere technique. The company has been issued a patent for its single-blastomere technology that provides an alternative manner of deriving human embryonic [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/act-receives-patent-generating-embryonic-stem-cells-embryo-destruction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Urethras to be Grown in Laboratories Now!</title>
		<link>http://pharmaexecnews.com/biotechnology/urethras-grown-laboratories/</link>
		<comments>http://pharmaexecnews.com/biotechnology/urethras-grown-laboratories/#comments</comments>
		<pubDate>Wed, 16 Mar 2011 14:00:13 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11312</guid>
		<description><![CDATA[For the first time in history, scientists have actually achieved to do the unthinkable! Giving proof of the actual advancement of science, researchers at the Institute for Regenerative Medicine at Wake Forest University Baptist Medical Center have announced that they have reached an all time new advance in tissue engineering. In a first in the [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/urethras-grown-laboratories/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Brain Enzyme that Erases/Brings Back Long-Term Memories</title>
		<link>http://pharmaexecnews.com/biotechnology/brain-enzyme-erasesbrings-longterm-memories/</link>
		<comments>http://pharmaexecnews.com/biotechnology/brain-enzyme-erasesbrings-longterm-memories/#comments</comments>
		<pubDate>Wed, 16 Mar 2011 08:00:12 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11307</guid>
		<description><![CDATA[A new research study conducted by the National Institutes of Health has shown that rats have a typical type of brain enzyme that can either enhance or erase long-term memories. By increasing or decreasing the enzyme, it is possible to control the enhancement of a memory, or erase it completely.

Sacktor, Yadin Dudai, Ph.D., of the Weizmann [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/brain-enzyme-erasesbrings-longterm-memories/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Link Discovered between Schizophrenia and Gene Mutation</title>
		<link>http://pharmaexecnews.com/biotechnology/link-discovered-schizophrenia-gene-mutation/</link>
		<comments>http://pharmaexecnews.com/biotechnology/link-discovered-schizophrenia-gene-mutation/#comments</comments>
		<pubDate>Fri, 11 Mar 2011 14:00:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene therapy]]></category>
		<category><![CDATA[genetics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11279</guid>
		<description><![CDATA[After many years of research, the reason behind what causes schizophrenia has finally come forward. Scientists, working in an international team, have finally discovered a gene mutation that is very strongly linked to causing schizophrenia. According to the researchers, the mutations in the VIPR2 gene increased the signaling in the vasoactive intestinal peptide pathway, which [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/link-discovered-schizophrenia-gene-mutation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>New Nanoparticles from MIT could lead to Vaccines for HIV, Malaria and Others</title>
		<link>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/</link>
		<comments>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/#comments</comments>
		<pubDate>Fri, 11 Mar 2011 08:00:16 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Immune Disorders]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[nano]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11275</guid>
		<description><![CDATA[While it might seem unbelievable, MIT engineers have announced that they have managed to design a new type of nanoparticles that could effectively and safely deliver vaccines for diseases such as malaria and HIV. HIV is known to be one of the biggest killers in the world and till now no one has been able [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/pharmaceuticals/drug-discovery/nanoparticles-mit-lead-vaccines-hiv-malaria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Transgenic Fungi to Treat Malaria</title>
		<link>http://pharmaexecnews.com/biotechnology/transgenic-fungi-treat-malaria/</link>
		<comments>http://pharmaexecnews.com/biotechnology/transgenic-fungi-treat-malaria/#comments</comments>
		<pubDate>Thu, 10 Mar 2011 14:29:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11268</guid>
		<description><![CDATA[Many developing countries are fighting the battle against malaria, with thousands of people dying every year due to malaria.  Now, new research from the University of  Maryland has indicated that a genetically engineered fungus might actually be able to cure malaria. The research team has proposed that a genetically engineered fungus carrying genes for [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/transgenic-fungi-treat-malaria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Genetic Differences between Cancer and Non-Cancer Patients</title>
		<link>http://pharmaexecnews.com/biotechnology/genetic-differences-cancer-noncancer-patients/</link>
		<comments>http://pharmaexecnews.com/biotechnology/genetic-differences-cancer-noncancer-patients/#comments</comments>
		<pubDate>Wed, 09 Mar 2011 14:00:30 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmacoeconomics]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[dna]]></category>
		<category><![CDATA[dna sequence]]></category>
		<category><![CDATA[Gene therapy]]></category>
		<category><![CDATA[genetics]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11260</guid>
		<description><![CDATA[New research from the Virginia Bioinformatics Institute (VBI) has proven that there are very specific changes in the genetic makeup of people suffering from cancer and those who don’t have cancer. The researchers from VBI have developed a new technology that catches these genetic changes, which help in differentiating cancer patients from healthy individuals. The [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/genetic-differences-cancer-noncancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Printers Used to Produce Human Skin?</title>
		<link>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/</link>
		<comments>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/#comments</comments>
		<pubDate>Thu, 03 Mar 2011 08:00:32 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[dna]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11211</guid>
		<description><![CDATA[U.S. medical researchers are using modified printers to produce skin for burn victims, the project&#8217;s leader says. &#8220;We started out by taking a typical desktop inkjet cartridge. Instead of ink we use cells, which are placed in the cartridge,&#8221; Dr. Anthony Atala, director of the Wake Forest Institute for Regenerative Medicine in Winston-Salem, N.C., told [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/printers-produce-human-skin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MedTrust, Avantra Partner to Develop Biomarker Assays for Cancer</title>
		<link>http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/</link>
		<comments>http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/#comments</comments>
		<pubDate>Mon, 28 Feb 2011 14:00:33 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[biochip]]></category>
		<category><![CDATA[biochips]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[pharmaceutical companies]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11234</guid>
		<description><![CDATA[MedTrust Online and Avantra Biosciences have entered into a partnership to involve clinicians in the earliest stages of molecular diagnostic assay development for Avantra Biosciences&#8217; revolutionary QPDx multiplex immunoassay system.

The two companies will provide over 10,000 cancer care professionals with early access to the latest panels of protein biomarkers implicated in different cancers.
Avantra had announced [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/medtrust-avantra-partner-develop-biomarker-assays-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gene &#8216;Relocation&#8217; Key to Most Evolutionary Change in Bacteria</title>
		<link>http://pharmaexecnews.com/biotechnology/gene-relocation-key-evolutionary-change-bacteria/</link>
		<comments>http://pharmaexecnews.com/biotechnology/gene-relocation-key-evolutionary-change-bacteria/#comments</comments>
		<pubDate>Mon, 07 Feb 2011 08:00:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11139</guid>
		<description><![CDATA[In a new study, scientists at the University  of Maryland and the Institut Pasteur show that bacteria evolve new abilities, such as antibiotic resistance, predominantly by acquiring genes from other bacteria. The researchers new insights into the evolution of bacteria partly contradict the widely accepted theory that new biological functions in bacteria and other [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/gene-relocation-key-evolutionary-change-bacteria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

